Concepedia

Mark W. Stahlhut

MW

49

Publications

3.1K

Citations

25

H-Index

1984

Active since

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Fox Chase Cancer Center

Ionis Pharmaceuticals (United States)

Mark W. Stahlhut is an author at United States Military Academy specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1984–2017

49

Publications

49

Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs

Steven S. Carroll, Joanne E. Tomassini, Michele Bosserman et al. · Journal of Biological Chemistry · 2003 · 336 citations · Full text

, , +17

Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro

Giovanni Migliaccio, Joanne E. Tomassini, Steven S. Carroll et al. · Journal of Biological Chemistry · 2003 · 324 citations · Full text

MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants

Vincenzo Summa, Steven W. Ludmerer, John A. McCauley et al. · Antimicrobial Agents and Chemotherapy · 2012 · 254 citations · Full text

A 7-Deaza-Adenosine Analog Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic Properties

David B. Olsen, Anne B. Eldrup, Linda Bartholomew et al. · Antimicrobial Agents and Chemotherapy · 2004 · 233 citations · Full text

, , +15

Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

Steven J. Harper, John A. McCauley, Michael T. Rudd et al. · ACS Medicinal Chemistry Letters · 2012 · 201 citations · Full text

, , +19

Rows per page

1–5 of 49